Bruker (Bruker) Price-to-Operating-Cash-Flow

: 32.60 (As of Today)

View and export this data going back to 2000. Start your Free Trial

As of today (2024-04-19), Bruker's share price is $77.76. Bruker's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $2.39. Hence, Bruker's Price-to-Operating-Cash-Flow Ratio for today is 32.60.

The historical rank and industry rank for Bruker's Price-to-Operating-Cash-Flow or its related term are showing as below:

BRKR' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 15.58 Med: 28.77 Max: 53.47
Current: 32.62

During the past 13 years, Bruker's highest Price-to-Operating-Cash-Flow Ratio was 53.47. The lowest was 15.58. And the median was 28.77.

BRKR's Price-to-Operating-Cash-Flow is ranked worse than
72.15% of 438 companies
in the Medical Devices & Instruments industry
Industry Median: 20.36 vs BRKR: 32.62

Bruker's Cash Flow from Operations per share for the three months ended in Dec. 2023 was $1.41. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $2.39.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Bruker was 29.50% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 3.40% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 8.80% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 11.90% per year.

During the past 13 years, Bruker's highest 3-Year average Operating Cash Flow per Share Growth Rate was 123.10% per year. The lowest was -145.20% per year. And the median was 9.10% per year.

Bruker Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Bruker's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bruker Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Operating-Cash-Flow

37.40

25.19

45.43

37.21

30.90

Bruker Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Price-to-Operating-Cash-Flow																37.21	40.96	32.01	29.11	30.90

Competitive Comparison

For the Medical Devices subindustry, Bruker's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bruker Price-to-Operating-Cash-Flow Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Bruker's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Bruker's Price-to-Operating-Cash-Flow falls into.

Bruker Price-to-Operating-Cash-Flow Calculation

Bruker's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	77.76	/	2.385
	=	32.60

Bruker's Share Price of today is $77.76.
Bruker's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.39.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Bruker Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Bruker's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Bruker (Bruker) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bruker Corp (NAS:BRKR) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

BKD:Germany

Address

40 Manning Road, Billerica, MA, USA, 01821

Website

https://www.bruker.com

Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, pharmaceutical, and biotechnology industries. It operates in four operating segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano and Bruker Energy and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives a majority of its revenue from Europe.

Executives

Frank H Laukien	director, 10 percent owner, officer: CEO, President	C/O BRUKER DALTONICS, 40 MANNING ROAD, BILLERICA MA 01821
Marc A Kastner	director	BRUKER CORPORATION, 40 MANNING ROAD, BILLERICA MA 01821
Cynthia M Friend	director	C/O BRUKER CORPORATION, 40 MANNING ROAD, BILLERICA MA 01821
Richard A Packer	director	9 KENDALL DRIVE, WESTBOROUGH MA 01581
Philip Ma	director	C/O BRUKER CORPORATION, 40 MANNING ROAD, BILLERICA MA 01821
Mark Munch	officer: Pres. Bruker Nano Inc.	BRUKER CORPORATION, 40 MANNING ROAD, BILLERICA MA 01821
Juergen Srega	officer: Group President Bruker CALID	BRUKER CORPORATION, 40 MANNING ROAD, BILLERICA MA 01821
Burkhard Prause	officer: Pres. & CEO, Bruker EST	BRUKER CORPORATION, 40 MANNING ROAD, BILLERICA MA 01821
Bonnie H Anderson	director	6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO CA 94080
Martin Gilles Gerard Jean	director	BRUKER CORPORATION, 40 MANNING ROAD, BILLERICA MA 01821
Falko Busse	officer: President, BioSpin Group	40 MANNING ROAD, BILLERICA MA 01821
Gerald N Herman	officer: Vice President, Corp Contr.	55 EXECUTIVE DRIVE, HUDSON NH 03051
Ingen Chris Van	director	395 PAGE MILL RD, MS A3 18, PALO ALTO CA 94306
Richard Kniss	director	395 PAGE MILL RD, MS A3 18, PALO ALTO CA 94306
Adelene Q Perkins	director	C/O INFINITY PHARMACEUTICALS, INC., 780 MEMORIAL DRIVE, CAMBRIDGE MA 02139